Ramipril and Olmesartan: Unveiling their pleiotropic potential as immunomodulators.

Dasan J, Yesunesan A, Chandran V, Mathew J, Mathew L

DOI: 10.4103/ijp.ijp_1245_25
Published: 2026 Sep 1
Container: Indian journal of pharmacology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.4103/ijp.ijp_1245_25,
  title = {Ramipril and Olmesartan: Unveiling their pleiotropic potential as immunomodulators.},
  author = {Dasan J and Yesunesan A and Chandran V and Mathew J and Mathew L},
  year = {2026},
  journal = {Indian journal of pharmacology},
  doi = {10.4103/ijp.ijp_1245_25},
  url = {https://doi.org/10.4103/ijp.ijp_1245_25}
}

RIS

TY  - JOUR
TI  - Ramipril and Olmesartan: Unveiling their pleiotropic potential as immunomodulators.
AU  - Dasan J
AU  - Yesunesan A
AU  - Chandran V
AU  - Mathew J
AU  - Mathew L
PY  - 2026
JO  - Indian journal of pharmacology
DO  - 10.4103/ijp.ijp_1245_25
UR  - https://doi.org/10.4103/ijp.ijp_1245_25
ER  -

APA

J, D., A, Y., V, C., J, M., & L, M. (2026). Ramipril and Olmesartan: Unveiling their pleiotropic potential as immunomodulators.. Indian journal of pharmacology. https://doi.org/10.4103/ijp.ijp_1245_25

Source records

pubmed · retrieved 2026-09-26T14:27:39.694Z